JP2023552180A5 - - Google Patents
Info
- Publication number
- JP2023552180A5 JP2023552180A5 JP2023532682A JP2023532682A JP2023552180A5 JP 2023552180 A5 JP2023552180 A5 JP 2023552180A5 JP 2023532682 A JP2023532682 A JP 2023532682A JP 2023532682 A JP2023532682 A JP 2023532682A JP 2023552180 A5 JP2023552180 A5 JP 2023552180A5
- Authority
- JP
- Japan
- Prior art keywords
- ascorbic acid
- pharmaceutical composition
- composition according
- sodium ascorbate
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EPPCT/EP2020/083363 | 2020-11-25 | ||
| PCT/EP2020/083363 WO2022111800A1 (en) | 2020-11-25 | 2020-11-25 | Stable formulations for radionuclide complexes |
| PCT/EP2021/082812 WO2022112323A1 (en) | 2020-11-25 | 2021-11-24 | Stable formulations for radionuclide complexes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023552180A JP2023552180A (ja) | 2023-12-14 |
| JP2023552180A5 true JP2023552180A5 (https=) | 2024-12-04 |
Family
ID=73598128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023532682A Pending JP2023552180A (ja) | 2020-11-25 | 2021-11-24 | 放射性核種錯体のための安定な製剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20240374732A1 (https=) |
| EP (1) | EP4251213A1 (https=) |
| JP (1) | JP2023552180A (https=) |
| KR (1) | KR20230134472A (https=) |
| CN (1) | CN116806144A (https=) |
| AU (1) | AU2021388832A1 (https=) |
| CA (1) | CA3171753A1 (https=) |
| WO (2) | WO2022111800A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4178628A4 (en) | 2020-07-13 | 2025-04-02 | Point Biopharma, Inc. | RADIOPHARMACEUTICALS AND PROCEDURES |
| US11541134B1 (en) | 2021-08-02 | 2023-01-03 | Rayzebio, Inc. | Stabilized compositions of radionuclides and uses thereof |
| JP2025505307A (ja) * | 2022-03-02 | 2025-02-21 | ポイント・バイオファーマ・インコーポレイテッド | 放射性医薬品及び方法 |
| US20250099634A1 (en) | 2023-09-25 | 2025-03-27 | Novartis Ag | Method of treating cancer |
| WO2025255398A1 (en) * | 2024-06-05 | 2025-12-11 | Ariceum Therapeutics Gmbh | Radiopharmaceutical composition and methods |
| US12343409B1 (en) * | 2024-06-05 | 2025-07-01 | Ariceum Therapeutics Gmbh | Radiopharmaceutical composition and methods |
| CN120733077B (zh) * | 2025-09-01 | 2025-12-05 | 杭州景嘉航生物医药科技有限公司 | 药物组合物及其制备方法与药物制剂 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5139678B2 (ja) * | 2003-07-24 | 2013-02-06 | ブラッコ・イメージング・ソシエタ・ペル・アチオニ | 安定な放射性医薬品組成物およびその製法 |
| AU2012294639B2 (en) | 2011-08-05 | 2017-10-26 | Molecular Insight Pharmaceuticals, Inc. | Radiolabeled prostate specific membrane antigen inhibitors |
| PL2970345T3 (pl) | 2013-03-15 | 2019-12-31 | Cancer Targeted Technology Llc | Znakowane 18F środki do obrazowania PET ukierunkowane na PSMA |
| EP2862857A1 (en) | 2013-10-18 | 2015-04-22 | Deutsches Krebsforschungszentrum | Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer |
| EP3456700A1 (en) | 2013-10-18 | 2019-03-20 | Deutsches Krebsforschungszentrum | Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer |
| CA3060143A1 (en) | 2017-05-24 | 2018-11-29 | Itm Isotopen Technologien Munchen Ag | Novel psma-binding agents and uses thereof |
| US10756278B2 (en) | 2017-07-18 | 2020-08-25 | Purdue Research Foundation | In situ thermal control of langmuir-schaefer transfer |
| US10596278B2 (en) | 2018-07-25 | 2020-03-24 | Advanced Accelerator Applications (Italy) S.R.L. | Stable, concentrated radionuclide complex solutions |
| WO2020108753A1 (en) | 2018-11-28 | 2020-06-04 | ITM Isotopen Technologien München AG | Novel tumor antigen binding agents and uses thereof |
-
2020
- 2020-11-25 WO PCT/EP2020/083363 patent/WO2022111800A1/en not_active Ceased
-
2021
- 2021-11-24 CA CA3171753A patent/CA3171753A1/en active Pending
- 2021-11-24 WO PCT/EP2021/082812 patent/WO2022112323A1/en not_active Ceased
- 2021-11-24 EP EP21815203.1A patent/EP4251213A1/en active Pending
- 2021-11-24 CN CN202180078162.5A patent/CN116806144A/zh active Pending
- 2021-11-24 AU AU2021388832A patent/AU2021388832A1/en active Pending
- 2021-11-24 KR KR1020237021396A patent/KR20230134472A/ko active Pending
- 2021-11-24 US US18/254,122 patent/US20240374732A1/en active Pending
- 2021-11-24 JP JP2023532682A patent/JP2023552180A/ja active Pending
-
2025
- 2025-01-17 US US19/028,880 patent/US12605447B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023552180A5 (https=) | ||
| CN102458396B (zh) | 使用抗坏血酸稳定化放射性药物组合物 | |
| JP2025111424A5 (https=) | ||
| US20090155167A1 (en) | Automated method | |
| AU2024227297A1 (en) | Methods for radiolabeling PSMA binding ligands and their kits | |
| TW201726586A (zh) | 同位素製備法 | |
| JP2015516457A (ja) | 放射性医薬品の製造用キット及び製造方法 | |
| RU2568888C1 (ru) | СПОСОБ И СОСТАВ ДЛЯ ПОЛУЧЕНИЯ РЕАГЕНТА ДЛЯ РАДИОНУКЛИДНОЙ ДИАГНОСТИКИ НА ОСНОВЕ МЕЧЕННОЙ ТЕХНЕЦИЕМ-99m 5-ТИО-D-ГЛЮКОЗЫ | |
| JP4345954B2 (ja) | 放射性医薬品の安定化剤 | |
| WO2023202730A2 (zh) | 放射性伊文思蓝衍生物药物水溶液及其制备方法和用途 | |
| JP4242465B2 (ja) | 放射線防護剤 | |
| CN117500773A (zh) | 在标记步骤期间制备具有低水含量的[18f]放射性标记化合物的方法 | |
| RU2846977C1 (ru) | Способы мечения радиоактивными изотопами psma-связывающих лигандов и наборы для их осуществления | |
| AU2010237040B9 (en) | Stabilization of radiopharmaceutical compositions using ascorbic acid | |
| HK1245645B (zh) | 使用抗坏血酸稳定化放射性药物组合物 | |
| HK1167344A (en) | Stabilization of radiopharmaceutical compositions using ascorbic acid | |
| HK1167344B (en) | Stabilization of radiopharmaceutical compositions using ascorbic acid | |
| HK1170672B (en) | Stabilization of radiopharmaceutical compositions using ascorbic acid | |
| HK1170672A (en) | Stabilization of radiopharmaceutical compositions using ascorbic acid |